Cargando…
Taking stock of gene therapy for cystic fibrosis
The identification of the cystic fibrosis (CF) gene opened the way for gene therapy. In the ten years since then, proof of principle in vitro and then in animal models in vivo has been followed by numerous clinical studies using both viral and non-viral vectors to transfer normal copies of the gene...
Autores principales: | Stern, Myra, Geddes, Duncan M, Alton, Eric WFW |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59546/ https://www.ncbi.nlm.nih.gov/pubmed/11667969 http://dx.doi.org/10.1186/rr16 |
Ejemplares similares
-
Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis
por: Ferrari, Stefano, et al.
Publicado: (2002) -
The Pathogenesis of Cystic Fibrosis and Progress Towards Gene Therapy
por: Stern, Myra, et al.
Publicado: (1999) -
Cystic Fibrosis Gene Therapy in the UK and Elsewhere
por: Griesenbach, Uta, et al.
Publicado: (2015) -
Gene Therapy for Lung Diseases
por: Alton, Eric W.F.W., et al.
Publicado: (2006) -
Recent advances in understanding and managing cystic fibrosis transmembrane conductance regulator dysfunction
por: Griesenbach, Uta, et al.
Publicado: (2015)